ACCELADX
LIVE

Serial Number

79414902

Owner

Cumulus Neuroscience Limited

Attorney

Steven J. Solomon

Filing Date

Jul 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ACCELADX Trademark

Serial Number: 79414902 • Registration: 7895575

ACCELADX is a trademark filed by Cumulus Neuroscience Limited on July 12, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Cumulus Neuroscience Limited (5 trademarks)

The Innovation Centre, Unit 4,

Entity Type: 99

Trademark Details

Filing Date

July 12, 2024

Registration Date

August 19, 2025

Published for Opposition

July 1, 2025

Goods & Services

Medical apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; medical apparatus and instruments, namely, sensors to be worn by a human for storing, relaying, tracking, measuring and displaying human cognitive and biometric data; medical apparatus and instruments for storing, relaying, tracking, and measuring the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological diseases, as well as brain injury or insult and mental illness in human beings and other animals, and for displaying associated neurological and psychiatric data; medical diagnostic and testing apparatus and instruments for detecting neurological diseases, brain injuries and mental illnesses; medical apparatus and instruments, namely, electroencephalogram (EEG) for the therapeutic and medical treatment of disease including neurological disease, brain injury, and mental illness; replacement and structural parts and fittings for the aforesaid goods

Design and development of computer software and computer programs for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; product development, namely, design and development of electronic apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; design and development of computer games software; design and development of computer software and mobile and tablet application software for the provision of medical and pharmaceutical information and reports; design and development of computer software and mobile and tablet application software for storing, relaying, tracking, measuring and displaying the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological disease, brain injury or insult and mental illness in human beings and other animals; product development, namely, design and development of wireless headsets; product development, namely, design and development of wireless headsets for playing video games, computer games and games downloadable on mobile electronic devices; product development, namely, design and development of sensors and detectors for scientific use to be worn by a human to gather biometric data; design and development of computer software and mobile and tablet application software for the diagnosis and treatment of medical conditions including neurological disease, brain injury, and mental illness; design and development of computer software and mobile and tablet application software for therapeutic and medical treatment of disease including neurological disease, brain injury, and mental illness; information, advisory and consultancy services in relation to the aforesaid services

Downloadable computer software and computer programs for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; electronic scientific laboratory research apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; downloadable computer games software; downloadable computer software and applications for the provision of medical and pharmaceutical information and reports; downloadable computer software and applications for storing, relaying, tracking, measuring and displaying the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological diseases, as well as brain injury, insult and mental illness in human beings and other animals; wireless headsets for smartphones and tablet computers; wireless headsets for playing video games, computer games and games downloadable on mobile electronic devices; sensors and detectors for scientific use to be worn by a human to gather human biometric data; downloadable computer software and applications for neuroimaging for use in the diagnosis and treatment of medical conditions including neurological disease, brain injury, and mental illness; replacement and structural parts and fittings for the aforesaid goods

Medical services; medical screening and testing services; medical evaluation services for neurological diseases; medical examination being health assessment services; neurological and cognitive testing and analysis for medical purposes; medical analysis for the diagnosis and treatment of persons; medical diagnostic services; medical advisory services, namely, measurement and prediction of response to medical treatments; human healthcare services, namely, neurology and psychiatric healthcare services; medical treatment services of neurological diseases, brain injuries and mental illnesses; medical diagnostic reporting services, namely, preparation of reports relating to medical matters; information, advisory and consultancy services in relation to the aforesaid services

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 20, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
May 28, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 28, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 28, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 28, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 20, 2025 GNFN
FINAL REFUSAL E-MAILED
May 20, 2025 GNFR
FINAL REFUSAL WRITTEN
May 20, 2025 CNFR
REFUSAL PROCESSED BY IB
Apr 5, 2025 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 31, 2025 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 28, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 28, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 28, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 28, 2025 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 13, 2025 RFCR
NON-FINAL ACTION WRITTEN
Feb 12, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 27, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 17, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 16, 2025 REPR